Considering the five hub genes, which were identified based on PPI networks and WGCNA, share the same signaling pathways during breast cancer progression, we conducted correlation analysis between the four novel hub genes (CENPL, ISG20L2, LSM4 and MRPL3) and EZH2. This evidence concerns the gene ISG20L2 and breast carcinoma.